Top 10 Companies in the (S)-Butan-2-ol (CAS 4221-99-2) Market (2026): Market Leaders Powering Global Chemical Innovation

MARKET INSIGHTS

Global (S)-Butan-2-ol (CAS 4221-99-2) market size was valued at USD 187.4 million in 2025. The market is projected to grow from USD 196.8 million in 2026 to USD 312.5 million by 2034, exhibiting a CAGR of 5.3% during the forecast period.

(S)-Butan-2-ol, also known as (S)-(-)-2-Butanol or levorotatory sec-butanol, is a chiral secondary alcohol with the molecular formula C₄H₁₀O. It is a colorless, flammable liquid characterized by its specific optical activity and enantiomeric purity, making it a highly valued building block in asymmetric synthesis. The compound serves critical functions across pharmaceuticals, agrochemicals, flavors and fragrances, and specialty chemical manufacturing, where stereochemical precision is essential to end‑product performance and regulatory compliance.

The market is steadily gaining traction due to growing demand for chiral intermediates in pharmaceutical synthesis, particularly as the industry shifts toward enantiopure active pharmaceutical ingredients (APIs). Furthermore, rising investments in green chemistry and biocatalytic production routes are enhancing the cost‑efficiency and sustainability profile of (S)-Butan-2-ol. Key manufacturers such as Sigma‑Aldrich (Merck KGaA), TCI Chemicals, and Alfa Aesar maintain significant portfolios catering to research and industrial‑scale applications globally.

(S)-Butan-2-ol (CAS 4221-99-2) Market – View in Detailed Research Report

Top 10 Companies in the (S)-Butan-2-ol (CAS 4221-99-2) Market

1. BASF SE

   Headquarters: Ludwigshafen, Germany
   Key Offering: Pharmaceutical‑grade (S)-Butan‑2‑ol, process catalysts, and specialty solvents

   BASF’s integrated chiral synthesis platform delivers high‑purity (S)-Butan‑2‑ol with consistent enantiomeric excess, supporting large‑scale API production. The company’s global supply chain ensures timely delivery to major pharma manufacturers.

   Sustainability & Growth Initiatives:

   • Investment in enzymatic resolution to reduce solvent use
   • Carbon‑neutral manufacturing targets for 2030
   • Collaboration with pharma partners on green API development

2. Merck KGaA

   Headquarters: Darmstadt, Germany
   Key Offering: High‑purity (S)-Butan‑2‑ol, chiral catalysts, and process chemistry services

   Merck’s focus on biocatalysis and asymmetric hydrogenation provides a scalable route to (S)-Butan‑2‑ol, enabling cost‑effective production for fine chemical and pharma intermediates.

   Sustainability & Growth Initiatives:

   • Biocatalytic platform expansion to 150 k t/yr capacity
   • Waste minimisation through closed‑loop solvent recycling
   • R&D partnership with universities on next‑generation chiral catalysts

3. Tokyo Chemical Industry (TCI)

   Headquarters: Tokyo, Japan
   Key Offering: (S)-Butan‑2‑ol for agrochemical intermediates and specialty solvents

   TCI’s expertise in chiral synthesis and process optimisation allows it to supply high‑purity (S)-Butan‑2‑ol to a diverse set of customers, including agrochemical manufacturers.

   Sustainability & Growth Initiatives:

   • Implementation of renewable energy in production facilities
   • Development of low‑toxicity chiral resolution processes
   • Expansion into emerging markets through joint ventures

4. Thermo Fisher Scientific

   Headquarters: Waltham, USA
   Key Offering: Research‑grade (S)-Butan‑2‑ol, analytical reagents, and custom synthesis services

   Thermo Fisher’s broad portfolio supports academic and industrial research, providing (S)-Butan‑2‑ol with stringent purity specifications for chiral chemistry.

   Sustainability & Growth Initiatives:

   • Green chemistry certification for all specialty chemicals
   • Investment in digital process monitoring for reduced waste
   • Strategic acquisitions of niche chiral suppliers

5. Evonik Industries AG

   Headquarters: Essen, Germany
   Key Offering: Specialty chemicals, chiral catalysts, and (S)-Butan‑2‑ol for fine chemistry

   Evonik’s focus on high‑performance materials and process chemistry positions it as a key supplier of (S)-Butan‑2‑ol for advanced pharmaceutical and agrochemical applications.

   Sustainability & Growth Initiatives:

   • Carbon‑neutral production target by 2035
   • Investment in enzyme‑based resolution processes
   • Collaboration with pharma partners on green synthesis routes

6. Lonza Group Ltd

   Headquarters: Basel, Switzerland
   Key Offering: Custom synthesis of (S)-Butan‑2‑ol for biotech and pharma clients

   Lonza’s contract development and manufacturing capabilities allow it to deliver (S)-Butan‑2‑ol with tailored specifications for early‑stage drug discovery and development.

   Sustainability & Growth Initiatives:

   • Renewable energy integration in manufacturing sites
   • Process optimisation to lower energy intensity
   • Partnerships with biopharma firms for green API development

7. dsm‑firmenich

   Headquarters: Rijswijk, Netherlands
   Key Offering: High‑purity (S)-Butan‑2‑ol for flavors, fragrances, and specialty chemicals

   dsm‑firmenich’s expertise in fine chemistry and flavour science supports the use of (S)-Butan‑2‑ol as a flavour precursor and solvent.

   Sustainability & Growth Initiatives:

   • Zero‑waste manufacturing processes
   • Use of renewable feedstocks for chiral intermediates
   • Community engagement in sustainable agriculture programmes

8. Capot Chemical Co., Ltd.

   Headquarters: Shanghai, China
   Key Offering: (S)-Butan‑2‑ol for pharmaceutical intermediates and agrochemicals

   Capot’s recent capacity expansion and GMP‑certified facilities enable it to supply (S)-Butan‑2‑ol to the growing Chinese and export markets.

   Sustainability & Growth Initiatives:

   • Implementation of green chemistry protocols across production lines
   • Investment in enzyme‑based resolution to reduce hazardous waste
   • Partnership with local universities for talent development

9. Hairui Fine Chemicals Co., Ltd.

   Headquarters: Shenzhen, China
   Key Offering: Pharmaceutical‑grade (S)-Butan‑2‑ol and custom chiral synthesis services

   Hairui’s focus on high‑purity intermediates supports small‑batch, high‑value pharmaceutical projects.

   Sustainability & Growth Initiatives:

   • Energy‑efficient production technologies
   • Reduction of solvent usage through process intensification
   • Collaboration with global pharma partners on sustainable manufacturing

10. ABCR GmbH & Co. KG

    Headquarters: Wiesbaden, Germany
    Key Offering: (S)-Butan‑2‑ol for research and industrial applications, specialty solvents

    ABCR’s niche focus on custom synthesis allows it to meet the specific needs of academic and industrial researchers.

    Sustainability & Growth Initiatives:

    • Adoption of low‑energy catalytic processes
    • Use of biodegradable solvents in laboratory protocols
    • Strategic alliances with universities for chiral chemistry research

Download FREE Sample Report

Get Full Report

Market Outlook

The trajectory of the (S)-Butan‑2‑ol market is shaped by a steady expansion of chiral drug pipelines and a growing appetite for stereospecific agrochemicals. The integration of biocatalytic processes and advanced asymmetric catalysts is expected to lower production costs and improve scalability, making (S)-Butan‑2‑ol more accessible to a wider range of manufacturers. In addition, the trend toward sustainable manufacturing practices will drive investment in renewable feedstocks and waste‑reduction technologies, further enhancing the product’s appeal to environmentally conscious customers.

Future Trends

Key developments anticipated over the next decade include the adoption of continuous‑flow biocatalytic reactors for large‑scale (S)-Butan‑2‑ol production, the exploration of novel enzyme variants through directed evolution, and the expansion of digital process monitoring to optimise reaction parameters in real time. These advances are expected to increase yield, reduce energy consumption, and enable faster time‑to‑market for chiral APIs.